Cooverexpression of Grb7 and ERBB2 are strongly associated with a worse prognosis than that of ERBB2 overexpression alone [63], suggesting the clinical significance of both Grb7 and ERBB2 genes/proteins expression in cancer development. Here, GRB7 is linked to cancer.